Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV-ACE/ASPECT: Pre-emptive CMV-specific T-cells in HSCT
NCT01220895Phase 2Completed
- Sponsor
- Kuur Therapeutics
- Start
- Oct 2010
- Primary completion
- Dec 2013
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Cytovir in cytomegalovirus infection (CMV), sponsored by Kuur Therapeutics. Started Oct 2010; status: completed.
02
Drugs
Cytovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT01220895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01220895.